Articles related to Neurology

A recent study found a 69 percent increased risk of Alzheimer’s diagnosis within a year of COVID-19 infection in individuals aged 65 years and older. This significant link between viral infections and Alzheimer’s disease could have major implications for our understanding of neurodegenerative diseases and their treatment.

A recent study found that more than 39% of MS patients had vitamin D levels below 20 ng/mL, which is considered deficient. This deficiency was associated with poorer cognition and greater disability, underscoring the importance of monitoring and managing vitamin D levels in MS patients.

Leqembi, a newly FDA-approved drug, has shown promising results in clinical trials, resulting in a 28% slower decline in Alzheimer’s patients compared to placebo. This equates to an additional four to five months of retained function.

Despite the potential benefits of ketamine in treating a range of neurological and psychiatric disorders, the FDA has issued warnings about the potential risks associated with its use, emphasizing the need for careful prescription and clinical oversight.

Recent studies have indicated a potential increase in stroke risk among seniors, particularly those aged 85 and older, who receive both COVID-19 and influenza vaccines simultaneously. This finding has sparked a renewed focus on the safety of administering multiple vaccines at the same time.

Healthcare professionals should be aware of the potential for neurological side effects in patients receiving COVID-19 vaccines. With nearly one-third of vaccine recipients experiencing symptoms such as headaches, tremors, and insomnia, continued monitoring and research are crucial.